Professor Luiz Moutinho (BA, MA, PhD, MAE, FCIM) is a Fellow and Visiting Professor of Marketing at Suffolk Business School, Faculty of Arts, Business and Applied Social Science, University of Suffolk, Ipswich, England, UK, and at The Marketing School, Portugal and Adjunct Professor of Marketing, Graduate School of Business, Faculty of Business and Economics, University of the South Pacific, Suva, Fiji. In 2020 he was elected as the member of The Academia Europaea. In 2017 he received a degree of Prof. Honoris Causa from the Univ. of Tourism and Management Skopje, North Macedonia. During 2015 - 2017 he was professor of BioMarketing and Futures Research at the DCU Business School, Dublin City University, Ireland. This was the first Chair in the world on both domains - BioMarketing and Futures Research. Previously, and for 20 years, he had been appointed as the Foundation Chair of Marketing at the Adam Smith Business School, University of Glasgow, Scotland. Previously, he got his first Chair in 1989 at the University of Wales College of Cardiff 1989-2006. Professor Moutinho completed his PhD at the University of Sheffield in 1982. He has been a Full Professor for 34 years and has held Visiting Professorship positions at numerous universities worldwide. He is the Founding Editor-in-Chief of the Journal of Modelling in Management (JM2) and Co-editor-in-Chief of the Innovative Marketing Journal. His main areas of research interest encompass marketing, management and tourism futurecast, artificial intelligence, biometrics and neuroscience theory, evolutionary algorithms, human-computer interaction, the use of artificial neural networks in marketing, modelling processes of consumer behaviour, futures research. Prof. Moutinho has given keynote speeches, lectures, seminars, talks, etc. in 46 countries worldwide. Prof. Moutinho has 38 books published, over 159 articles published in refereed academic journals. He has 16250 academic citations, the h-index of 59 and the i10-index of 160 (Google Scholar, August 12th, 2023).

Dr. Pedro A. Jose is Professor of Medicine, University of Maryland School of Medicine, Adjunct Professor of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine and Visiting Professor, Third Military Medical University of the People’s Republic of China, Chongqing, P.R. China and Anhui Institute of Cardiovascular Disease, Anhui Provincial Hospital, Anhui, P.R. China. He has been invited as a guest lecturer in several universities in Australia, China, France, Germany, Ireland, Japan, Portugal, Sweden, Philippines, and USA and plenary speaker in several international meetings of learned societies. Dr. Jose received his MD degree, magna cum laude, meritissimus, from the University of Santo Tomas, Philippines, and placed first in the Philippine National Board Examinations in Medicine and Surgery. He received his PhD degree in Physiology from Georgetown University, Washington, DC and defended his dissertation with distinction. He is certified by the American Board of Pediatrics, American Sub-Board of Pediatric Nephrology, and American Society of Hypertension. He was President of the American Society of Pediatric Nephrology. Dr. Jose has chaired and continues to chair Study Sections and Emphasis Panels of the US National Institutes of Health and voluntary organizations, such as the American Heart Association and National Kidney Foundation. He reviews grant applications in foreign countries, including Italy and the Czech Republic. Dr. Jose has extensive experience in basic and translational research. The primary goal of Dr. Jose’s research is to determine the genetic bases of human essential hypertension. He has published over 340 scientific articles in prestigious journals and books including Circulation Research, Hypertension, Journal of the American Society of Nephrology, Journal of Clinical Investigation, Nature Genetics, and Proceedings of the National Academy of Sciences. His publications are cited more than 7,800 times with 41 cited more than 50 times, 17 of which are cited more than 100 times; four are covers of scientific journals and six are the subject of editorial commentaries. Dr. Jose has received several academic awards, including the 2003 Lewis K. Dahl Memorial Lecture (Council for High Blood Pressure Research, American Heart Association), 2007 Ernest H. Starling Distinguished Lecture (American Physiological Society Water and Electrolyte Homeostasis Section) and a 2007 MERIT award from the National Institutes of Health. He is a fellow of the Council for High Blood Pressure Research, American Heart Association. A key finding of Dr. Jose’s research is the demonstration of the crucial role of variants of a gene “G protein-coupled receptor kinase type 4 or GRK4” in the pathogenesis of high blood pressure in humans. Dr. Jose also showed that variations of GRK4 are very important in predisposing an individual to develop salt-sensitive high blood pressure. These studies have resulted in a patent in the US (# 6,660,474) and Japan (#4652566), patent-pending in Europe and Australia) and a provisional patent on “Compositions and Methods for Identifying and Diagnosing Salt Sensitivity of Blood Pressure” (US Provisional Patent Application #61,636,576).Variants of GRK4 may also predict the response to anti-hypertensive drugs, an example of pharmacogenomics. Four of his National Institutes of Health research grant applications received perfect scores of 10 (Project 3 of 5P01HL074940 [2009], Project 4 of 5P01HL068686 [2012], HL092196 [2013], and R01DK039308 [2011]). Dr. Jose’s research is currently funded by three R01 grants in which he is the principal investigator, two P01 grants in which he is the director of program projects, and one grant from pharma. Deciphering the role of GRK4 gene variants, in the pathogenesis of human essential hypertension, was the second advance and discovery cited by the Director of NHLBI for its FY 2004 Budget Justification to the US Congress.

Dr. Bing-Huei Chen received his Ph.D. degree in Food Science & Technology, Texas A & M University, USA. He is a Distinguished Chair Professor at Fu Jen University, Taipei, Taiwan. Dr. Bing-Huei Chen has published over 174 research articles in internationally renowned journals and authored 11 book chapters in edited books published by International Publishers. He has been honored with a young scientist award and outstanding research award by the Taiwan Association of Food Science & Technology. He also serves as Editor-in-Chief of 2 journals.

Dr Marika Cordaro graduated in biology at the University of Messina in 2015. She has completed his PhD in “Applied Biology and Experimental Medicine” at University of Messina, Italy in the year 2017. She is a researcher in physiology, with particular interest in cell physiology and molecular mechanism underling inflammation. In particular, Dr Cordaro, during her research activity, produced about 120 articles that attest a diffuse interest in the field of inflammation and oxidative stress neurological disorder-related. Her research is involved in preclinical studies for the discovery of physiological cellular response that could be used as new potential therapeutic targets. Dr. Cordaro have knowledge about animals research, behavioral alterations, biochemical and molecular biology and immunohistochemical analysis.

Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner, Parenteral and Enteral Medical Nutrition Therapist, Acupuncture, Pain Management and Homeopathy. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Author of the theory Constitutional Homeopathy of the Five Elements Based on Traditional Chinese Medicine. Author of more than 230 publications about treatment of variety of diseases rebalancing the internal energy.

Dr. Malegiannaki Amaryllis-Chryssi is an Adjunct Lecturer at the Aristotle University of Thessaloniki, Greece, and at the University of Nicosia, Cyprus. She held the position of chief psychologist at the Rehabilitation Unit of the Psychiatric Clinic of Veroia, Greece, and supervised postgraduate students’ training in psychological assessment. She has authored several scientific articles and books in the field of neuropsychology and cognitive development. Her current research interests include, and neuropsychological research with genetic syndromes and ADHD, and the development of computerized neuropsychological assessment tools. She has been a reviewer and a member of the editorial board in various scientific psychology and medical journals. Her contribution to research has been awarded by the Research Committee of the Aristotle University of Thessaloniki.

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior, he was an Erasmus Student at Faculty de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hired as a Postdoctoral Scholar in the Department of Pharmacology and Physiology at the University of South Florida in Tampa, on two research grants funded by the Office of Naval Research (US Navy) and Divers’ Alert Network. He has written and lectured widely worldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters.

Education: Faculty of Pharmacy, Medical University, Lublin, Poland; Master’s degree (highest honor), Department of Biochemistry; Doctoral thesis in pharmacology (highest honor), Department of Pharmacodynamics; Habilitation thesis in Pharmacology (highest honor), idem; since 2010–Full Professor degree, now: the Head of the Chair and Department of Pharmacology and Pharmacodynamics; since 2012 – Vice-Dean of the Faculty of Pharmacy with Medical Analitics Division, Medical University of Lublin, Poland. 1991-2009: Recipient of seven fellowships of French and Polish Government; in total 5 years of training and regular post in Paris; 9 Erasmus Plus training. Author of 230 papers, tutor of 10 doctoral thesis, number of citations: 1500; citation index=22. Review of papers for international and polish journals: 233; of scientific grants: 117, principle investigator of polish and international (”Polonium”) grants and UE projects. Member of 15 Editorial Board of open-access journals. Member of the Polish Academy of Science Commissions. Languages: Polish: native; French: fluently; English, Russian. Research subjects: psychopharmacology, pharmacotherapy, experimental pharmacology. The central effects of psychoactive drugs and natural products (including locomotor sensitization, cross-sensitization, place conditioning and withdrawal syndrome, chronic mild unpredictable stress), anxiety, memory and learning, depression, nociception, Parkinson and Alzheimer disease, psychosis, measured in behavioral paradigms. The common molecular mechanisms shared by addiction and memory processes; the neurobiological mechanisms of drug dependence (the influence of endocannabinoid system, calcium homeostasis and kinases/phosphatases balance) and further strategies for its pharmacotherapy.

Luca Roncati, MD-PhD, DMLS, is Associate Editor of the European Journal of Gynaecological Oncology (EJGO), Medical Executive at the University Hospital of Modena, and Adjunct Professor at the University of Modena and Reggio Emilia (Italy). Eponym of the Roncati-Manenti triad and describer of T rex lymphoma, he is the author of more than 250 academic publications, he has taken part in the scientific work of various national and international agencies or research groups, he has organized several conferences of national relevance, he has attended as a speaker at numerous congresses and seminars, he holds the intellectual property of an Italian and international patent for anticancer therapy, and he has obtained various national and supranational awards.

Dr Fusco completed her PhD in Applied Biology and Experimental Medicine by University of Messina and Yale University School of Medicine. She worked as researcher for studies on biochemical activities (in vitro primary cultures and in vivo experimental models) for the Epitech Group, biological company. Now she is an Assistant Professor of Biochemistry at the Chemical, Biological, Pharmaceutical and Enviromental Science Department of the University of Messina, Italy. Dr Fusco has a long-lasting expertise in the induction and management of in vitro and in vivo models of inflammation and oxidative stress, which is documented by more than 100 papers published on international refereed journals. Her areas of scientific interest are the role of oxidative stress in autoimmunity, inflammation and neurodegenerative disorders; nutritional antioxidants and modulation of signal pathway.

Professor Luiz Moutinho (BA, MA, PhD, MAE, FCIM) is a Fellow and Visiting Professor of Marketing at Suffolk Business School, Faculty of Arts, Business and Applied Social Science, University of Suffolk, Ipswich, England, UK, and at The Marketing School, Portugal and Adjunct Professor of Marketing, Graduate School of Business, Faculty of Business and Economics, University of the South Pacific, Suva, Fiji. In 2020 he was elected as the member of The Academia Europaea. In 2017 he received a degree of Prof. Honoris Causa from the Univ. of Tourism and Management Skopje, North Macedonia. During 2015 - 2017 he was professor of BioMarketing and Futures Research at the DCU Business School, Dublin City University, Ireland. This was the first Chair in the world on both domains - BioMarketing and Futures Research. Previously, and for 20 years, he had been appointed as the Foundation Chair of Marketing at the Adam Smith Business School, University of Glasgow, Scotland. Previously, he got his first Chair in 1989 at the University of Wales College of Cardiff 1989-2006. Professor Moutinho completed his PhD at the University of Sheffield in 1982. He has been a Full Professor for 34 years and has held Visiting Professorship positions at numerous universities worldwide. He is the Founding Editor-in-Chief of the Journal of Modelling in Management (JM2) and Co-editor-in-Chief of the Innovative Marketing Journal. His main areas of research interest encompass marketing, management and tourism futurecast, artificial intelligence, biometrics and neuroscience theory, evolutionary algorithms, human-computer interaction, the use of artificial neural networks in marketing, modelling processes of consumer behaviour, futures research. Prof. Moutinho has given keynote speeches, lectures, seminars, talks, etc. in 46 countries worldwide. Prof. Moutinho has 38 books published, over 159 articles published in refereed academic journals. He has 16250 academic citations, the h-index of 59 and the i10-index of 160 (Google Scholar, August 12th, 2023).

Ann Marie O’Connor is an Education Assistant for Grades K-12, where she works primarily with students who suffer from FAS/ ADHD and ODD. She is also a Canadian Advocate for Epilepsy and former Vice President for the Edmonton and Northern Alberta Epilepsy Association, where she was on the Board of Directors for over 11 years. She has published two books and had several articles written on her behalf (Surgical Neurology International/Your Health Magazine/Spruce Grove Examiner) as well as she has been interviewed on Global Edmonton and Breakfast Television Edmonton. Her topics of discussion are Women and Epilepsy-Sex and Seizures-Depression-Side effects of R-Her surgery-Books published. In Canada alone, an average of 42 people a day learn that they have Epilepsy and over 50 million people worldwide suffer from the disorder. I can say that I Beat Epilepsy. It was 6:30 AM on December 03, 2002. I remember being wheeled down the hall at the University of Alberta Hospital in Edmonton, Alberta, Canada by the porter with the silence it felt like we were the only ones in the building. You could hear a pin drop. I had lived with epilepsy for almost 20 years of my life and that was about to change. Left selective Amygdalohippocampectomy is the surgery I was about to undergo and it is what cured me of my seizures. The left parahippocampal gyrus, left amygdale and left hippocampus were removed; structures within the left temporal lobe. I had 6 seizures 2 days before the surgery and I have not had one since. Since my surgery, I have accomplished some amazing tasks in my life. I have written two books, was asked to be a Canadian Advocate for Epilepsy in 2012 and have been a motivational speaker for over 8 years. Helping others is my passion, is my calling. I want to educate others internationally from a patient’s point of view, help them understand that they are not alone when it comes to living with epilepsy